Boston Scientific lobbied on 8 issues. See lobbying
Its wordsWhat does this committee say it is for?
No published list of positions
This committee’s site publishes no list of positions we could read, and we found no statement of why it exists. We do not write one for it.
Who it gives toWhich candidates and committees get its money?
Each part reads different filings, so counts and totals can differ.
Party support distribution$255K to 90 candidates
Direct PAC contributions and independent expenditures explicitly reported as support, by the party of the candidate they went to.
For candidates $255,000
Republican 56%
Democratic 33%
Support by the party of the candidate
Party of the candidate
Candidates
Direct
Independent
Amount
Share
Republican
49
$144,000
$0
$144,000
56%
Democratic
30
$84,000
$0
$84,000
33%
Other or unresolved
11
$27,000
$0
$27,000
11%
Shown support
90
$255,000
$0
$255,000
100%
Contributions are reported money, not endorsements; a PAC giving to both parties is common.
Who this PAC gave to$380,000 in 184 payments
Every contribution on line 23 of the committee’s own Schedule B, which is the filing its summary totals are built from. That line covers federal candidates, party committees and other political committees alike, so a super PAC funding other super PACs appears here rather than under candidate giving.
By recipient
Line 23 contributions by kind and party of recipient
Recipient
Count
Amount
Democratic candidates
30
$84K · 22%
Republican candidates
48
$143K · 37%
Other or unresolved candidates
12
$28K · 7.3%
Other PACs and committees
27
$127K · 33%
All recipients
117
$382K
By the candidate’s state
Contributions to candidates by the candidate’s state
State
Candidates
Amount
Massachusetts
4
$21.5K
California
7
$21K
Indiana
5
$18.5K
Florida
8
$18.5K
Louisiana
3
$12.5K
Pennsylvania
5
$12K
Texas
5
$11.5K
Missouri
2
$11K
The largest 8 of 36 states.
Recipients 117
Show candidate activity and the money network
Candidate and election activity as the recipients filed it
Katherine Clark3 receipts, latest Jun 23, 2026Katherine Clark for Congress · H4MA05084$10K
John E. Sununu2 receipts, latest Sep 16, 2026Sununu Senator · S6NH00208$10K
Jason T. Smith2 receipts, latest Mar 25, 2026Jason Smith for Congress · H4MO08162$10K
Jay Obernolte2 receipts, latest Sep 24, 2026Jay Obernolte for Congress · H0CA08135$8.5K
Todd Christopher Young3 receipts, latest Sep 24, 2026Friends of Todd Young, Inc. · S6IN00191$7.5K
Candidate contribution rows come from candidate committee Schedule A filings, the same rows the party chart above counts.
Committee money network
Money moving between this committee and other committees, matched on FEC committee ID rather than the name each filing was typed under. Both sides exclude memo entries. The figures here count each committee once, from the itemized transfers read for this section, so they will not match the payment counts under Who this PAC gave to.
Committees funding this one
Committees that reported giving to this one on their own Schedule A filings, grouped by the giver’s committee ID.
Committees funding this one
Name
Amount
Mullin for AmericaSenate campaign committee · Connected to MULLIN VICTORY FUND · 1 payment
$2.5K
$2.5K from 1 committee, counting every itemized receipt this cycle.
Committees this one funds
Disbursements this committee itemized to another committee: candidate contributions, party transfers and payments alike, not contributions only.
CHC Bold PACPAC (qualified) · Connected to ELECT DIVERSE DEMOCRATS PAC · 2 payments
$10K
Defend the DreamPAC (qualified) · Connected to PADILLA · 2 payments
Money inWho funds the PAC?
Where the money came from $404,292 reported receipts
Itemized (over $200)Donors who have given more than $200 this cycle, so the FEC itemizes (names) them.$221,33055%
Largest donors
Susan E. Morano2 contributions, latest May 12, 2026 · BOARD OF DIRECTORS · BOSTON SCIENTIFIC · WASHINGTON, DC$10,000
Cheryl Pegus2 contributions, latest May 12, 2026 · BOARD OF DIRECTORS · BOSTON SCIENTIFIC CORPORATION · LAS VEGAS, NV$10,000
David Wichmann2 contributions, latest Jan 9, 2026 · DIRECTOR, BOARD OF DIRECTORS · BOSTON SCIENTIFIC CORPORATION · EDINA, MN$10,000
Ellen Zane2 contributions, latest May 12, 2026 · BOARD OF DIRECTORS · BOSTON SCIENTIFIC CORPORATION · HINGHAM, MA$10,000
Brenda Becker20 contributions, latest Aug 28, 2026 · SR VP, GOV AFFAIRS/R&OP · BOSTON SCIENTIFIC CORPORATION · WASHINGTON, DC$8,064
Joseph Fitzgerald20 contributions, latest Aug 28, 2026 · EXEC. VP, PRES RHYTHM MGT. · BOSTON SCIENTIFIC CORPORATION · EDINA, MN$8,064
Michael Mahoney20 contributions, latest Aug 28, 2026 · CHAIRMAN AND CEO · BOSTON SCIENTIFIC CORPORATION · BARRINGTON, RI$8,064
Mary Beth Moynihan20 contributions, latest Aug 28, 2026 · CORP. MARKETING & MARKET ACCESS · BOSTON SCIENTIFIC · BOSTON, MA$8,064
Meghan Scanlon15 contributions, latest Aug 28, 2026 · SVP, & PRESIDENT, UROLOGY AND PELVIC H · BOSTON SCIENTIFIC · DUXBURY, MA$5,952
Stephen Morse16 contributions, latest Aug 28, 2026 · VP, SALES & MKTG · BOSTON SCIENTIFIC · WOODBURY, MN$5,820
Arthur Butcher21 contributions, latest Aug 28, 2026 · SVP & PRESIDENT, ENDOSCOPY · BOSTON SCIENTIFIC CORPORATION · WELLESLEY, MA$5,288
Edward LudwigOne contribution on Feb 12, 2026 · BOARD OF DIRECTORS · BOSTON SCIENTIFIC CORPORATION · DEMAREST, NJ$5,000
A donor who gave several times appears once. The 12 largest donors by total given are listed. In all, 1,784 itemized contributions were filed this cycle, totaling $206.3K. FEC contributor lists are public records and cannot be used for commercial solicitation.
Unitemized ($200 or less)Donors who have given $200 or less this cycle, so the FEC does not itemize (name) them.$177,96244%
Refunds and rebatesMoney coming back to the committee: rebates and refunds of what it spent, contributions it made that were returned, and loans it made that were repaid.$5,0001.2%
Total reported receipts $404,292
Every dollar the committee reported receiving this cycle, split by the source the FEC filing attributes it to. Open a source marked + to see who gave. FEC filings through Oct 14, 2026.
Who donated: where they live, their employers and jobs
Where the donors live $206,258 placed by state
Loading the map
Tap or hover over a state, or focus the map and use the arrow keys, to read its total. Ctrl or ⌘ and scroll to zoom.
under $2.3K
$2.3K+
$9.3K+
$20.9K+
$37.2K+
none
Top states
Top donor states
Name
Amount
Minnesota499 contributions · 28%
$58,165
Massachusetts429 contributions · 27%
$56,520
District of Columbia54 contributions · 10%
$21,414
Florida168 contributions · 5.5%
$11,315
Nevada7 contributions · 4.9%
SpendingWhere does the money go?
How the spending splits $389,428 reported
Contributions to candidates and other committeesMoney given to federal candidates, party committees and other PACs.$385,00099%
Operating expendituresThe committee's own running costs.$4,4231.1%
Paid to
Susan Hyre Paperworks1 payment · latest May 6, 2026 · PAYMENT FOR PAC MERCH$3,077
The Scoby Brothers2 payments · latest Oct 21, 2025 · CHECK FOR PAC MERCH VENDOR$1,346
Contribution refundsMoney returned to the people and committees that gave it.$5<0.1%
Total reported disbursements $389,428
Every dollar this committee reported spending this cycle, split by the lines it reports against. Open a line to see who was actually paid on it. FEC filings through Oct 14, 2026.
What the payments were for $384,423 itemized
Given to othersContributions to other candidates, party committees, and PACs.$380,00099%
Filed as
CONTRIBUTION$380,000
Paid to
The EYE of the Tiger PAC$10,000
Committee for Hispanic Causes/building Our Leadership Diversity PAC$10,000
Defend the Dream$10,000
Hispanic Leadership Trust$10,000
Heartland Values PAC$10,000
Jason Smith for Congress$10,000
OtherPayments whose filed description does not match any category above. Every one is listed so it can be read directly.$4,4231.2%
Filed as
PAYMENT FOR PAC MERCH$3,077
CHECK FOR PAC MERCH VENDOR$673
CHECK FOR PAC MERCH VENDOR - SECOND ORDER$673
Paid to
Susan Hyre Paperworks$3,077
The Scoby Brothers$1,346
Total itemized disbursements $384,423
Every itemized payment the committee reported this cycle, sorted by what it said each one was for. The categories are ours; the wording they are matched against is the committee’s own. Open a category to read the filed descriptions and who was paid. FEC filings through Oct 14, 2026.
Spending over time
$394.9K spent from Jan 2025 to Oct 2026. Most in one report: $72K, June 2025.
$394.9K
Jan 2025Oct 2026
The running total of what the committee’s FEC reports say it spent, independent expenditures included, with a point at the end of each report. The line is straight between reports because a report gives one total for its whole period.
300 BOSTON SCIENTIFIC WAYMARLBOROUGH, MA, 01752-1291
Audits and penalties
None published by the FEC
LobbyingWhat does its sponsor lobby on?
What Boston Scientific lobbies on 2026 reports
Besides giving through its PAC, Boston Scientific pays lobbyists to press Congress and federal agencies. Each quarter it, or a firm it hires, files a public report under the Lobbying Disclosure Act saying which topics it worked on, what it spent, and whom it contacted. This is what those reports say.
Spent on lobbying in 2026
$1.9M
Quarterly reports read
16
Bills it named
19
Topics it lobbied on
Each report files its work under official topics. The bar shows how often each topic came up across the reports; open one to read what was filed under it. Naming a bill says the organization lobbied on it, not which side it took.
Taxation/Internal Revenue Codein 9 report entries · 2 bills named
In its own words
OECD 2 Pillar Framework Implementation - International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs Act (H.R. 591) and the Unfair Tax Prevention Act (H.R.2423), legislation regarding extraterritorial taxation and completion/implementation of the G7 side-by-side agreement.
Ensuring Patient Access to Critical Breakthrough Products Act of 2025(H.R. 5343 and S.1717) - Legislation to create automatic CMS coverage for devices approved via FDA's breakthrough pathway.
(CMS rulemaking for Transitional Coverage of Emerging Technologies (TCET) - advocacy for a new, voluntary Transitional Coverage of Emerging Technologies (TCET) pathway that provides national Medicare coverage for Breakthrough-designated technologies, beginning on the date of FDA market authorization.) The Patient Access to Innovative New Technologies Act (PAINT Act) -- proposed legislation that aims to expand access to new medical technologies by improving the Medicare New Technology Add-on Payment (NTAP) program.
It would create a single deadline for products in an alternative pathway, ensure breakthrough devices are eligible for conditional approval under NTAP, and prevent disruption in Medicare beneficiaries' access to new treatments.
The Advancing Research for Chronic Pain Act (S. 5041), directs the CDC to regularly collect, analyze, and report data on the prevalence, burden, and impact of chronic pain in the US and build a centralized Chronic Pain Information Hub.
The Relief of Chronic Pain Act (S. 3064), which would lower cost-sharing and bar step therapy and prior authorization for non-opioid treatments under Medicare Part D. Starting work on the Food and Drug Omnibus Reform Act of 2026 (Public Law 117-328) - advocacy efforts on Medical Device User Fee Amendments (MDUFA) reauthorization, riders, and device shortages.
Trade (domestic/foreign)in 6 report entries
In its own words
Supply Chain - advocacy efforts on topics that could potentially impact the medical device supply chain such as decisions made by the United States House Select Committee on Strategic Competition between the United States and the Chinese Communist Party, outbound investments, raw materials, components, export controls, and shortage/supply chain resiliency reporting regulations.
Submitted comments for the U.S. Dept of Commerce's investigation to determine the effects on the national security of imports of medical equipment including medical devices.
Discussed the unique aspects and critical contributions of the U.S. medical technology sector as related to tariffs and other trade measures on imported medical devices and components and our support for policies that do not harm domestic manufacturing and global competition in the sector.
Advocacy concerning trade issues.
Offices it contacted
HOUSE OF REPRESENTATIVES
SENATE
Commerce, Dept of (DOC)
Veteransin 6 report entries · 4 bills named
In its own words
Medical device procurement and supply chain resiliency.
Ensuring VHA patient access to Med Tech as VHA manages supply chain and upgrades its medical surgery and prosthetics procurement contracting.
Pain management - working to increase veteran access to multidisciplinary and multimodal pain management to provide for effective non-opioid treatment alternatives, specifically H.R.6835.
VA Authorization Bill of 2025- Specifically, H.R. 6549 The VA Contracting and Procurement Act.
This bill would reform VAs contracting process by modernizing medical implant acquisition and consolidating billing for surgical procedures to enhance delivery of care to veterans.
FY2027 Appropriations: Advocacy efforts on including report language in Labor-HHS to advance non-opioid, evidence-based pain management and in VA/DoD accounts to support modernization of procurement processes, including a transparent product add cycle and a streamlined single purchase order mechanism.
Take Care of American Veterans Act: Specifically advocating for modernizing the VA's prosthetics and implant procurement program by increasing resources, expanding clinical and procurement expertise, and requiring implementation of a nationwide electronic ordering system.
Pain management - working to increase veteran access to multidisciplinary and multimodal pain management to provide for effective non-opioid treatment alternatives.
Medicare/Medicaidin 4 report entries · 3 bills named
In its own words
Physician payment and policy issues relating to dialysis vascular access services; H.R.7863 - Promoting Fairness for Medicare Providers Act of 2026; H.R. 9693 - Patients First Act of 2026
Physician payment and policy issues relating to dialysis vascular access services; H.R.7863 - Promoting Fairness for Medicare Providers Act of 2026
Medicare Physician Fee Schedule; Medicare Physician Fee Schedule reform; H.R.10136 - Promoting Fairness for Medicare Providers Act of 2024.
EPA Rulemaking Restricting Ethylene Oxide (ETO) - Proposed rulemaking to place more-stringent limits on emissions and institute new monitoring requirements for ethylene oxide (ETO).
Advocacy efforts include educating lawmakers on the importance of ETO in the sterilization of medical devices and potential shortages of sterile medical devices if EPA's proposed changes are enacted.
Offices it contacted
HOUSE OF REPRESENTATIVES
SENATE
Manufacturingin 2 report entries · 2 bills named
In its own words
Issues related to FY2027 National Defense Authorization Act (NDAA) (S. 4784 & H.R. 8800) - Advocacy efforts on right to repair (RTR) proposals impacting servicing and repair of medical devices.
Specifically, the Reform of Technical Data and Software Rights to Support Competition, Sustainment, and Readiness (section 861 of H.R. 8800), the Modifications to Technical Data Rights (section 804 of S. 4784), and other provisions related to healthcare and proprietary data.
Science/Technologyin 2 report entries · 2 bills named
In its own words
Issues related to the U.S. House discussion draft of the Great American AI Act (GAAIA) - Advocacy and education efforts on the importance of FDA retaining regulatory authority over AI used in medical devices, and on redundant or potentially harmful regulations that could impair patient access to devices or hinder innovation.
Issues related to SECURE Data Act (H.R. 8413) - Advocacy for the inclusion of healthcare-related carveouts with exemptions for HIPAA covered entities and business associates, health records, and certain clinical research and patient-safety data.
Also, advocacy for the inclusion of language preempting state frameworks by establishing a single federal standard.
Issues related to the Health Care Cybersecurity and Resiliency Act of 2026 (S.3315) - Advocacy related to the inclusion of language excluding medical device manufacturers from S. 3315 SEC. 8.
Issues related to cybersecurity, including reauthorization of the Cybersecurity Information Sharing Act of 2015.
Brick Street StrategyLobbying firm · 3 reports$60K
Liberty Partners Group, LLCLobbying firm · 4 reportsNot reported
Contributions on the LD-203 report
Reported twice a year by the lobbying filer. $72.3K is political giving that also appears in FEC filings.
Representative Haley Stevens (D-MI-11)$11K
Representative John Larson (D-CT-01)$8K
Rep. Haley Stevens$7K
Representative Diana DeGette (D-CO-01)$5.5K
New Dems PAC$5K
Roy Cooper for North Carolina$5K
Roy Cooper$3.5K
Democratic Congressional Campaign Committee$3K
Representative Andrea Salinas D-OR-06)$3K
Rep. Raja Krishnamoorthi (D-IL-08)$2K
Matched by name: these reports are filed for “BOSTON SCIENTIFIC (OFFICE-BASED FACILITY ASSN OBFA) (FKA USPA)”, found by searching “BOSTON SCIENTIFIC”. Lobbying and FEC records share no ID, so an organization that lobbies under another name is missed. Source: LDA.gov, accessed Oct 26, 2026. Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.
BOSTON SCIENTIFIC CORPORATION POLITICAL ACTION COMMITTEE (BSC PAC)
Filings covered
Through Oct 14, 2026
Data source
FEC bulk filing data
Boston Scientific Corp. PAC is registered with the Federal Election Commission as a PAC (qualified). It is a lobbyist/registrant PAC. Its FEC record names Boston Scientific Corp. as an affiliate. Official FEC summary: Federal Election Commission committee record.
Pages quoted 0 pages
No pages quoted
Nothing from this committee’s or its sponsor’s site is quoted yet.
Linked public records
No approved organization identity yet
The official FEC committee record remains available under Filings.
JSJason SmithRepublican · U.S. House · MO-08 · via Jason Smith For Congress2 payments, latest Mar 25, 2026 · CONTRIBUTION · FEC filing, Mar 25, 2026$10K
Menendez for CongressHouse campaign committee · Connected to BETTER BLUE FUND · 2 payments
$7.5K
$382K across 121 recipient committees, or 98% of everything this committee reports spending. The largest 12 are shown. A further $4K was filed as memo entries, which FEC reports separately to avoid counting it twice.
Built from FEC Schedule A and Schedule B filings for the selected cycle. A committee only appears here if the money was itemized under its FEC committee ID.
$10,165
Rhode Island36 contributions · 4.3%
$8,804
Virginia59 contributions · 4.1%
$8,430
New Jersey1 contribution · 2.4%
$5,000
By the state each contributor wrote on the filing. The FEC aggregates every Schedule A line together, so one committee or organization transfer can account for a whole state. Contributors who have given $200 or less this cycle are not itemized and cannot be placed on a map. The FEC’s grouping also counts joint-fundraising memo lines, so these rows can add up to more than the itemized total.
Donors’ employers as filed
Donors’ employers
Employer as filed
Amount
Boston Scientific Corporation1,711 contributions · 99% of ranked
$203,328
BSC36 contributions · 0.7% of ranked
$1,535
Peripheral11 contributions · 0.3% of ranked
$520
Bsci7 contributions · 0.1% of ranked
$255
Neuromodulation5 contributions · <0.1% of ranked
$180
CRM5 contributions · <0.1% of ranked
$165
Boston Scientific - NMD2 contributions · <0.1% of ranked
$75
Boston Scienfific1 contribution · <0.1% of ranked
$60
A further $80 came from donors whose answer names no employer (blank), so it is not ranked. Itemized receipts grouped by the words contributors filed. The FEC aggregates every Schedule A line here, so committee and organization money sits alongside individuals; this is not an industry classification. The FEC’s grouping also counts joint-fundraising memo lines, so these rows can add up to more than the itemized total. Gifts of $200 or less ($177,962) are not itemized, so no employer or occupation is filed for them.
Donors’ occupations as filed
Donors’ occupations
Occupation as filed
Amount
Board Of Directors7 contributions · 17% of ranked
$35,000
Director Board Of Directors3 contributions · 5.9% of ranked
$12,000
Director Government Affairs58 contributions · 4.5% of ranked
$9,210
Chairman And CEO20 contributions · 4% of ranked
$8,064
Corp Marketing & Market Access20 contributions · 4% of ranked
$8,064
Exec VP Pres Rhythm MGT20 contributions · 4% of ranked
$8,064
SR VP GOV Affairs/r&op20 contributions · 4% of ranked
$8,064
Director Sales135 contributions · 3.9% of ranked
$7,980
A further $2,570 came from donors whose answer names no occupation (blank), so it is not ranked. Itemized receipts grouped by the words contributors filed. The FEC aggregates every Schedule A line here, so committee and organization money sits alongside individuals; this is not an industry classification. The FEC’s grouping also counts joint-fundraising memo lines, so these rows can add up to more than the itemized total. Gifts of $200 or less ($177,962) are not itemized, so no employer or occupation is filed for them.
All 187 itemized payments filed this cycle. Spending below the itemization threshold is not filed line by line.
The people, firms and committees paid the most, across every kind of payment. Each share is of everything the committee reported spending this cycle, not only the itemized payments above. A payee that is itself a committee links to its own profile.
Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) (Public Law 109-417) - advocacy on risk mitigation plans and voluntary shortage reporting related to medical device supply chains and advocacy for medical research and to foster a new era of medical innovation and prepare for future pandemics and promote health equity.
Support passage of the Radiation Oncology Case Rate (ROCR) Value Based Payment Program Act of 2025 - Senate (S. 1031) & (H.R. 2120).
This legislation would increase access to patient care, enhance the quality of cancer treatments, encourage innovation, reduce disparities for rural and underserved patients, and lower patient costs by saving Medicare about $200 million over 10 years.
The WISeR Model (Wasteful and Inappropriate Service Reduction Model) - Advocacy efforts on inclusions in CMS' WISeR model, which is aimed at reducing inappropriate care and preventing improper payments under Medicare Part B by refining prior authorization processes for traditional fee-for-service Medicare.
Engaged on the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway and efforts to streamline FDA-CMS coordination and Medicare coverage for Breakthrough Devices.
It would create a single deadline for products in an alternative pathway, ensure breakthrough devices are eligible for conditional approval under NTAP, and prevent disruption in Medicare beneficiaries' access to new treatments. 2025 Reauthorization of the SUPPORT for Patients and Communities Act - Advocacy for reauthorization of the SUPPORT Act, specifically for FDA approved alternative treatments for Chronic Pain, and medical devices role to address the opioid epidemic.
Starting work on the Food and Drug Omnibus Reform Act of 2026 (Public Law 117-328) - advocacy efforts on Medical Device User Fee Amendments (MDUFA) reauthorization, riders, and device shortages.
Issues concerning Medicare reimbursement, AI and medical technology.
Medical Supply Chain program reforms, MSPV, PSAS, IT HR 6549, VA Contracting and Procurement Act HR 9237, Taking Care of Veterans Act S2918, Veterans Prosthetics Advancement and Reform Act
Medical Supply Chain program reforms HR 6549, VA Contracting and Procurement Act
